Mark Guthrie is currently a Global Access Strategy Leader for Oncology at Roche, focusing on Lung, Skin, and Rare Mutations. With over 15 years in the global pricing and reimbursement environment, they have previously led various initiatives in immunology and infectious diseases, driving business unit revenue growth through strategic partnerships and trials. Mark has substantial experience representing Genentech before US Federal policymakers and has developed comprehensive pricing strategies for major pharmaceutical markets, including the US and abroad. Mark holds an MBA in Healthcare Management and a BA in Economics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices